282 related articles for article (PubMed ID: 36432422)
1. Adipose Tissue Dysfunction in Obesity: Role of Mineralocorticoid Receptor.
Parasiliti-Caprino M; Bollati M; Merlo FD; Ghigo E; Maccario M; Bo S
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432422
[TBL] [Abstract][Full Text] [Related]
2. The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.
Jia G; Aroor AR; Sowers JR
Cardiovasc Res; 2017 Jul; 113(9):1055-1063. PubMed ID: 28838041
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor.
Lefranc C; Friederich-Persson M; Palacios-Ramirez R; Nguyen Dinh Cat A
J Endocrinol; 2018 Sep; 238(3):R143-R159. PubMed ID: 29875164
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR/GR).
Even SE; Dulak-Lis MG; Touyz RM; Nguyen Dinh Cat A
Horm Mol Biol Clin Investig; 2014 Aug; 19(2):89-101. PubMed ID: 25390018
[TBL] [Abstract][Full Text] [Related]
5. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice.
Hirata A; Maeda N; Hiuge A; Hibuse T; Fujita K; Okada T; Kihara S; Funahashi T; Shimomura I
Cardiovasc Res; 2009 Oct; 84(1):164-72. PubMed ID: 19505930
[TBL] [Abstract][Full Text] [Related]
6. Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction.
Hirata A; Maeda N; Nakatsuji H; Hiuge-Shimizu A; Okada T; Funahashi T; Shimomura I
Biochem Biophys Res Commun; 2012 Mar; 419(2):182-7. PubMed ID: 22326264
[TBL] [Abstract][Full Text] [Related]
7. The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses.
Hoppmann J; Perwitz N; Meier B; Fasshauer M; Hadaschik D; Lehnert H; Klein J
J Endocrinol; 2010 Feb; 204(2):153-64. PubMed ID: 19939912
[TBL] [Abstract][Full Text] [Related]
8. Cellular mechanisms of MR regulation of adipose tissue physiology and pathophysiology.
Armani A; Marzolla V; Fabbri A; Caprio M
J Mol Endocrinol; 2015 Oct; 55(2):R1-10. PubMed ID: 26272942
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease.
Gorini S; Marzolla V; Mammi C; Armani A; Caprio M
Biomolecules; 2018 Sep; 8(3):. PubMed ID: 30231508
[TBL] [Abstract][Full Text] [Related]
10. Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity.
Feraco A; Armani A; Mammi C; Fabbri A; Rosano GM; Caprio M
J Steroid Biochem Mol Biol; 2013 Sep; 137():99-106. PubMed ID: 23454117
[TBL] [Abstract][Full Text] [Related]
11. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity.
Schäfer N; Lohmann C; Winnik S; van Tits LJ; Miranda MX; Vergopoulos A; Ruschitzka F; Nussberger J; Berger S; Lüscher TF; Verrey F; Matter CM
Eur Heart J; 2013 Dec; 34(45):3515-24. PubMed ID: 23594590
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid Receptors in Metabolic Syndrome: From Physiology to Disease.
Feraco A; Marzolla V; Scuteri A; Armani A; Caprio M
Trends Endocrinol Metab; 2020 Mar; 31(3):205-217. PubMed ID: 31843490
[TBL] [Abstract][Full Text] [Related]
13. MR (Mineralocorticoid Receptor) Induces Adipose Tissue Senescence and Mitochondrial Dysfunction Leading to Vascular Dysfunction in Obesity.
Lefranc C; Friederich-Persson M; Braud L; Palacios-Ramirez R; Karlsson S; Boujardine N; Motterlini R; Jaisser F; Nguyen Dinh Cat A
Hypertension; 2019 Feb; 73(2):458-468. PubMed ID: 30624990
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction.
Bender SB; DeMarco VG; Padilla J; Jenkins NT; Habibi J; Garro M; Pulakat L; Aroor AR; Jaffe IZ; Sowers JR
Hypertension; 2015 May; 65(5):1082-8. PubMed ID: 25712719
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome.
Marzolla V; Armani A; Feraco A; De Martino MU; Fabbri A; Rosano G; Caprio M
Steroids; 2014 Dec; 91():46-53. PubMed ID: 24819992
[TBL] [Abstract][Full Text] [Related]
16. Potential role of progestogens in the control of adipose tissue and salt sensitivity via interaction with the mineralocorticoid receptor.
Caprio M; Zennaro MC; Fève B; Mammi C; Fabbri A; Rosano G
Climacteric; 2008 Jun; 11(3):258-64. PubMed ID: 18568791
[TBL] [Abstract][Full Text] [Related]
17. The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism.
Marzolla V; Armani A; Zennaro MC; Cinti F; Mammi C; Fabbri A; Rosano GM; Caprio M
Mol Cell Endocrinol; 2012 Mar; 350(2):281-8. PubMed ID: 21945603
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders.
Garg R; Adler GK
Curr Hypertens Rep; 2015 Jul; 17(7):52. PubMed ID: 26068659
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists.
Ronconi V; Turchi F; Appolloni G; di Tizio V; Boscaro M; Giacchetti G
Curr Vasc Pharmacol; 2012 Mar; 10(2):238-46. PubMed ID: 22022770
[TBL] [Abstract][Full Text] [Related]
20. Impact of MR on mature adipocytes in high-fat/high-sucrose diet-induced obesity.
Hayakawa T; Minemura T; Onodera T; Shin J; Okuno Y; Fukuhara A; Otsuki M; Shimomura I
J Endocrinol; 2018 Oct; 239(1):63–71. PubMed ID: 30307154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
